GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 18, Issue 4, 2011, Pages

  Boodram, Basmattee ^a   Hershow, R C ^a   Klinzman, D ^b   Stapleton, J T ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Co infection; GB virus C; Hepatitis C virus; Injection drug users; Prevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; DISEASE ASSOCIATION; DRUG USE; FEMALE; HEPATITIS C; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPACIVIRUS; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; PREVALENCE; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD; YOUNG ADULT;

EID: 79952655205     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01350.x     Document Type: Article

References (33)

1. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562.
2. WHO. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999; 6: 35-47.
3. Kennedy N, Tong CY, Beeching NJ et al. Hepatitis G virus infection in drug users in Liverpool. J Infect 1998; 37: 140-147. (Pubitemid 28482917)
4. Schreier E, Hohne M, Kunkel U, Berg T, Hopf U. Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany. J Hepatol 1996; 25: 385-389. (Pubitemid 26323478)
5. Thomas DL, Nakatsuji Y, Shih JW et al. Persistence and clinical significance of hepatitis G virus infections in injecting drug users. J Infect Dis 1997; 176: 586-592. (Pubitemid 27360521)
6. Yan J, Dennin RH. A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany. World J Gastroenterol 2000; 6: 833-841. (Pubitemid 32015799)
7. Stark K, Bienzle U, Hess G, Engel AM, Hegenscheid B, Schluter V. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174: 1320-1323. (Pubitemid 26393913)
8. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005; 9: 383-398. vi.
9. NIH. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements 2002; 19: 1-46.
10. Stapleton JT. GB virus type C/Hepatitis G virus. Semin Liver Dis 2003; 23: 137-148. (Pubitemid 36666683)
11. Alter HJ. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 1997; 37: 569-572.
12. Berzsenyi MD, Bowden DS, Kelly HA et al. Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection. Gastroenterology 2007; 133: 1821-1830. (Pubitemid 350180804)
13. Jung S, Knauer O, Donhauser N et al. Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors. AIDS 2005; 19: 1267-1272. (Pubitemid 41224895)
14. Mohr EL, Stapleton JT. GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat 2009; 16: 757-768.
15. Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 2004; 363: 2040-2046. (Pubitemid 38781104)
16. Lefrere JJ, Roudot-Thoraval F, Morand-Joubert L et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179: 783-789. (Pubitemid 29159322)
17. Williams CF, Klinzman D, Yamashita TE et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004; 350: 981-990. (Pubitemid 38269275)
18. Chu C, Hwang S, Luo J et al. Clinical, virological, immunological, and pathological significance of GB virus C/hepatitis G infection in patients with chronic hepatitis C. Hepatol Res 2001; 19: 225-236. (Pubitemid 32241901)
19. Goeser T, Seipp S, Wahl R, Muller HM, Stremmel W, Theilmann L. Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C. J Hepatol 1997; 26: 498-502. (Pubitemid 27112713)
20. Manolakopoulos S, Morris A, Davies S, Brown D, Hajat S, Dusheiko G. Influence of GB virus C viraemia on the clinical, virological and histological features of early hepatitis C-related hepatic disease. J Hepatol 1998; 28: 173-178. (Pubitemid 28116422)
21. Pereira LM, Spinelli V, Ximenes RA et al. Chronic hepatitis C infection: influence of the viral load, genotypes, and GBV-C/HGV coinfection on the severity of the disease in a Brazilian population. J Med Virol 2002; 67: 27-32. (Pubitemid 34260072)
22. Saitoh H, Moriyama M, Matsumura H, Goto I, Tanaka N, Aarakawa Y. The clinical significance of GBV-C/HGV exposure in C-viral chronic liver disease and blood donors. Hepatol Res 2002; 22: 288-296. (Pubitemid 34498386)
23. Shev S, Bjorkman P, Norkrans G et al. GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors. J Med Virol 1998; 54: 75-79. (Pubitemid 28080845)
24. Slimane SB, Albrecht JK, Fang JW et al. Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients. J Viral Hepat 2000; 7: 51-55. (Pubitemid 30139852)
25. Tan D, Matsumoto A, Conry-Cantilena C et al. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. J Infect Dis 1999; 179: 1055-1061. (Pubitemid 29196482)
26. Souza IE, Allen JB, Xiang J et al. Effect of primer selection on estimates of GB virus C (GBV-C) prevalence and response to antiretroviral therapy for optimal testing for GBV-C viremia. J Clin Microbiol 2006; 44: 3105-3113. (Pubitemid 44413738)
27. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002; 36: S21-S29. (Pubitemid 35253460)
28. Farci P, Purcell RH. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis 2000; 20: 103-126. (Pubitemid 30421412)
29. Orii K, Tanaka E, Rokuhara A et al. Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus. Intervirology 2000; 43: 139-145.
30. Tanaka E, Alter HJ, Nakatsuji Y et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996; 125: 740-743. (Pubitemid 126450362)
31. Oshita M, Hayashi N, Mita E et al. GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapy. J Med Virol 1998; 55: 98-102. (Pubitemid 28221611)
32. Ramezani A, Gachkar L, Eslamifar A et al. Detection of hepatitis G virus envelope protein E2 antibody in blood donors. Int J Infect Dis 2008; 12: 57-61. (Pubitemid 350299226)
33. Devereux H, Sabin CA, Kinson Z et al. Influence of HIV-1 infection on GBV-C infection in multiply infected haemophilic patients. J Med Virol 1998; 56: 316-320. (Pubitemid 28516598)